DentiTrac Oral Appliance System

NEW GOLD STANDARD IN WEARABLE COMPLIANCE MEASUREMENT RECEIVES TAP ORAL APPLIANCE FDA CLEARANCE TEST. TREAT. TRAC. ® 25th August 2016:

BRAEBON Medical Corporation announces today that the DentiTrac® oral appliance compliance system has passed a substantial regulatory hurdle and is now FDA cleared in the USA for use with the Airway Management TAP® family of oral devices. BRAEBON congratulates Airway Management for achieving this milestone. The DentiTrac® system has been developed by BRAEBON. It is a wearable microrecorder and web cloud portal combination which defines the new gold standard for the objective measurement of oral appliance compliance measurement for sleep apnea. DentiTrac® is an integrated wearable microrecorder embedded inside an oral appliance to reliably and accurately gather detailed information to confirm a patient is following prescribed therapy. The information is then uploaded to the BRAEBON cloud portal where physicians and dentists can conveniently and securely review patient information and assess sleep apnea therapy adherence.

“We are very pleased DentiTrac® is expanding its footprint in the US market. Accurate oral appliance compliance measurement is needed to level the playing field with traditional sleep apnea treatment called CPAP. In addition, the ability to reliably measure sleep apnea treatment adherence is a vital requirement for insurance payers. Oral appliance therapy for obstructive sleep apnea is the number one alternative to CPAP and we anticipate this will contribute to significant overall growth in the burgeoning field of dental sleep medicine and the use of oral appliance therapy for sleep apnea. The DentiTrac® is the final realization of the BRAEBON Test Treat Trac® strategy which empowers clinicians across multiple disciplines to efficiently and collaboratively work together to more effectively manage the sleep apnea patient,” said Dr. Richard Bonato, CEO and Co-Founder. “The challenge was to develop a measurement technology which could not be easily deceived. This was vital because new US Federal DOT legislation will impact everyone in the transportation industry including all truck drivers, pilots, bus drivers, etc. We had to invent a novel and powerful solution which we’ve secured with IP patent protection. The level of product sophistication connected with our cloud portal is beyond anything we’ve done before. I’m very proud of what our team has accomplished,” said Donald Bradley, CTO and Co-Founder.

“Airway Management has an agreement in place with BRAEBON,” said Airway Management Founder, Dr. Keith Thornton. “We look forward to working closely together to roll-out TAP with DentiTrac to target markets in the USA, and subsequently to the rest of the world,” he added. About BRAEBON Medical Corporation BRAEBON is a privately held Canadian corporation and has been in business since 1998 developing and manufacturing medical devices for snoring and sleep apnea in their ISO 13485 manufacturing facility. BRAEBON’s products are sold worldwide for use in the Sleep Medicine and Dental Sleep Medicine fields. BRAEBON is a world leader in portable home sleep apnea testing devices with its MediByte® and MediByte Jr.® recorders as well as its line of sleep sensors and accessories. For additional information contact Mr. Mitch Livingston, VP Business Development, by telephone at 613.831.6690 x220, via email at mitchl@braebon.com or visit BRAEBON at www.braebon.com.